Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
BACKGROUND Patients with a bicuspid aortic valve (BAV) are at risk for aortic dilatation over time, which can increase the risk of dissection. Some patients are treated with beta blockers or afterload reducing agents to slow the rate of aortic dilation, but their effectiveness is not established in children. METHODS AND RESULTS This is a retrospective observational cohort study of 558 patients with a BAV and ascending aorta (AscAo) dilatation from 9 Canadian pediatric cardiology programs.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
